Tuesday, September 22, 2015

Turing to cut pricing for Daraprim amid backlash


Turing to cut pricing for Daraprim amid backlash
The company's decision to hike the drug's price by more than 5,500 percent was the subject of a recent New York Times story. In a phone call with NBC News, Turing's Martin Shkreli said he will cut the cost of treatment in response to the public outcry.

September 22, 2015 at 06:56PM
via Digg http://ift.tt/1L4rHC6

No comments:

Post a Comment